NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed comprehensive national plan for the millions of family caregivers across the country who tirelessly care for their loved ones—including those living with Alzheimer’s—often while also trying to balance a family and a career, and dealing with health issues of their own. AFA also urged Washington to build off this positive step by increasing National Institutes of Health (NIH) funding for Alzheimer’s research.
“We are grateful to Congress and President Trump for all their hard work in making this critical legislation a reality. The importance of supporting our nation’s families and easing the devastation of this cruel disease is surely something on which we can all agree,” said Charles J. Fuschillo, Jr., AFA’s President and CEO. “This is forward progress, but it should not be the end of the journey.”
“This encouraging development is only the tip of the iceberg,” Fuschillo added. “A dire need remains for the federal government to pass a Fiscal Year (FY) 2018 budget which includes $2 billion—up from the current amount of $1.4 billion—for Alzheimer’s disease research at the NIH. $2 billion is the minimum amount leading scientists insist is needed to finding an Alzheimer’s cure or meaningful treatment by 2025, as called for by the National Plan to Address Alzheimer’s Disease. Washington must come together again in the same spirit of bipartisanship it just showed with the RAISE Family Caregiver Act and provide the necessary research funding.”
Alzheimer’s is the sixth leading cause of death in the United States, and the only one in the top ten without a cure or reversible treatment. The death rate from Alzheimer’s grew by more than 54 percent between 1999 and 2014, according to a Centers for Disease Control report issued last May. More than five million Americans are currently living with Alzheimer’s disease and waiting for a cure.
“Passing the RAISE Family Caregiver Act was a great first step for 2018,” Fuschillo said, “but the federal government can, and must, take a giant step forward by significantly increasing funding for Alzheimer’s research.”
More on the new law
The RAISE Family Caregiver Act will require the Federal Government to develop a national strategy to support family caregivers; it will bring together stakeholders from the private and public sectors to recommend actions and develop a comprehensive national plan that communities, providers, government and others can follow to make the responsibilities of caregiving a little easier.
About the Alzheimer’s Foundation of America (AFA):
The Alzheimer’s Foundation of America, based in New York, is a non-profit organization that unites more than 2,600 member organizations nationwide in the goal of providing optimal care and services to individuals living with dementia, and to their caregivers and families. Its services include a national, toll-free helpline (866-232-8484) staffed by licensed social workers, educational conferences and materials, a free quarterly magazine for caregivers, the National Memory Screening Program, and “AFA Partners in Care” dementia care training for healthcare professionals. For more information about AFA, call 866-232-8484, visit www.alzfdn.org, follow us on Twitter, or connect with us on Facebook or LinkedIn.
CONTACT:
Sandy Silverstein
866-232-8484, ext. 104
ssilverstein@alzfdn.org
Karin Eskenazi
Public Relations Manager
Alzheimer’s Foundation of America
322 Eighth Avenue, Fl 7
New York, NY 10001
Office: 866-232-8484
Email: keskenazi@alzfdn.org
Website: AFA